Vaccines and Disease Relapses in Children with Nephrotic Syndrome

Andrea Angeletti; Maurizio Bruschi; Silvia Bianchin; Irene Bonato; Carolina Montobbio; Enrico Verrina; Francesca Lugani; Paolo Cravedi; Gian Marco Ghiggeri

doi:10.2215/CJN.01890221

Vaccines and Disease Relapses in Children with Nephrotic Syndrome

Clin J Am Soc Nephrol. 2021 Jun;16(6):937-938. doi: 10.2215/CJN.01890221. Epub 2021 Jun 11.

Authors

Andrea Angeletti¹, Maurizio Bruschi², Silvia Bianchin¹, Irene Bonato¹, Carolina Montobbio¹, Enrico Verrina¹, Francesca Lugani², Paolo Cravedi³, Gian Marco Ghiggeri¹

Affiliations

¹ Division of Nephrology, Dialysis, and Transplantation, Instituto di ricovero e cura a carattere scientifico (IRRCS) Instituto Giannina Gaslini Children's Hospital, Genoa, Italy.
² Laboratory of Molecular Nephrology and Division of Nephrology and Transplantation, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
³ Renal Division, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.

No abstract available

Keywords: COVID-19; children; idiopathic nephrotic syndrome; nephrotic syndrome; pediatric nephrology; rituximab; steroid dependent nephrotic syndrome; vaccines.

Publication types

Randomized Controlled Trial

MeSH terms

Adolescent
Antibodies, Monoclonal, Humanized / therapeutic use
B-Lymphocytes
COVID-19 / prevention & control*
COVID-19 Vaccines
Child
Child, Preschool
Diphtheria-Tetanus-acellular Pertussis Vaccines
Female
Humans
Immunologic Factors / therapeutic use*
Infant
Influenza Vaccines
Male
Nephrotic Syndrome / drug therapy*
Nephrotic Syndrome / immunology*
Poliovirus Vaccine, Inactivated
Recurrence
Rituximab / therapeutic use
SARS-CoV-2
Vaccines*
Young Adult

Substances

Antibodies, Monoclonal, Humanized
COVID-19 Vaccines
Diphtheria-Tetanus-acellular Pertussis Vaccines
Immunologic Factors
Influenza Vaccines
Poliovirus Vaccine, Inactivated
Vaccines
Rituximab
ofatumumab